FDA Drug Application (090524) for TRI-LINYAH by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number090524
Product Number001
FormTABLET;ORAL-28
Dosage0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRI-LINYAH
Active IngredientETHINYL ESTRADIOL; NORGESTIMATE



Back to FDA Applications sponsored by NOVAST LABS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.